1
|
Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
|
Cancer Res
|
2010
|
1.91
|
2
|
STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
|
Biochem Biophys Res Commun
|
2011
|
1.13
|
3
|
A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.
|
Mol Cancer
|
2010
|
1.05
|
4
|
Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines.
|
Mol Cancer Ther
|
2009
|
1.04
|
5
|
New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
|
Cancer Sci
|
2009
|
1.01
|
6
|
HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.
|
Clin Cancer Res
|
2013
|
1.00
|
7
|
IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.
|
Cell Cycle
|
2010
|
0.94
|
8
|
Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.
|
Anticancer Drugs
|
2009
|
0.88
|
9
|
Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
|
FEBS J
|
2013
|
0.85
|
10
|
Reversal of negative charges on the surface of Escherichia coli thioredoxin: pockets versus protrusions.
|
Biochemistry
|
2004
|
0.81
|